CARMELINA(トラゼンタ)EASD10月4日発表済(Unpublished) https://t.co/J5Bt9vSLn6 https://t.co/FZ3DyYz6Ea https://t.co/FzRPtiRHtN EWTOPIA75(ゼチーア)AHA Late Breaking Clinical Trial 11月10日(Unpublished) https://t.co/TyDO6C4PTc
8,060 followers
1,028 followers
Rationale, design, and baseline characteristics of the CArdiovascular safety and Renal Microvascular outcomE study with LINAgliptin (CARMELINA®): a randomized, double-blind, placebo-controlled clinical trial in patients with type 2 diabetes and high cardio
494 followers
Estudio CARMELINA, ya nos están contando lo bien diseñado que está y el alto riesgo de enfermedad renal de los pacientes incluidos... ¿Anticipando resultados mediocres? Pronto lo veremos https://t.co/mxlu5vXazJ
1,314 followers
CARMELINA trial methods and baseline characteristics nearly 7000 patients with diabetes, 74% have eGFR<60 mL/min or macroalbuminuria. This will be an important trial @VladoPerkovic https://t.co/KDZxiSXxnG